Athenahealth on Thursday rebuffed claims that its shareholders were pressing the company to accept a $7 billion acquisition proposal from billionaire Paul Singer’s activist investor firm Elliott Management.

While the healthcare technology company is still considering the $160 per share cash offer, Athenahealth said it disagreed with a letter sent by Elliott on Thursday, which claimed that its stockholders were supportive of the deal.